Juliet Gyebifoster, MD
Pain Medicine · Ijamsville, MDNPI 1801113022
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,325 of the $6,626 with a category attached, or 65.3%. 38 manufacturers reported payments, led by Abbott at 35.6% of the total. Reporting peaked in 2020 at $2,056 and has fallen 79.1% since, to $429 in 2025.
Across 186 payments — averaging $35.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$2K
- Collegium Pharmaceutical, Inc.$271
- Medtronic$245
- AbbVie$241
- SPR Therapeutics, Inc$197
- plus $1K from 32 others
What the payments were for
- Travel & lodging$2,28935%
- Food & beverage$4,32565%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 49 | $2,359 |
| Boston Scientific | 31 | $1,890 |
| Collegium Pharmaceutical, Inc. | 17 | $271 |
| Medtronic | 5 | $245 |
| AbbVie | 11 | $241 |
| SPR Therapeutics, Inc | 3 | $197 |
| MML US, Inc. | 1 | $153 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $113 |
| Averitas Pharma Inc. | 3 | $85 |
| Pacira Therapeutics, Inc. | 4 | $81 |
| AstraZeneca | 4 | $76 |
| Ferring Pharmaceuticals Inc. | 4 | $70 |
| Pfizer | 4 | $70 |
| Bioventus LLC | 3 | $67 |
| Vertos Medical, Inc. | 2 | $63 |
| Lilly USA, LLC | 5 | $63 |
| Stryker | 3 | $51 |
| Upsher-smith Laboratories LLC | 2 | $51 |
| Biotronik NRO, Inc. | 1 | $44 |
| Painteq LLC | 2 | $41 |
| MDD US Operations, LLC | 2 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Novartis | 2 | $31 |
| Curonix LLC | 2 | $31 |
| Tersera Therapeutics LLC | 2 | $30 |
| Amgen(2 entities) | 2 | $29 |
| Daiichi Sankyo Inc. | 2 | $27 |
| Protega Pharmaceutials Inc | 1 | $24 |
| Saluda Medical Americas, Inc. | 1 | $22 |
| Si-bone, Inc. | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| UCB, Inc. | 1 | $14 |
| Tanabe Pharma America, Inc. | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
| Shionogi Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,626 in reported general payments places this provider in the 75th percentile of 144 pain medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 11 | $1,071 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 55 | $1,039 |
| Gabapentin | 84 | $493 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $443 |
| Morphine Sulfate ErMorphine Sulfate | 27 | $419 |
| Baclofen | 17 | $306 |
| Oxycodone Hcl | 15 | $209 |
| Tramadol Hcl | 56 | $197 |
| Duloxetine Hcl | 15 | $173 |
| Tramadol Hcl ErTramadol Hcl | 13 | $136 |
| Tizanidine Hcl | 15 | $131 |
| Hydromorphone Hcl | 15 | $125 |
| Meloxicam | 33 | $55 |
| Celecoxib | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Ijamsville
- Vipul MangalOxon Hill$764K
- Randy DavisBaltimore$169K
- Paul ChristoBaltimore$137K
- Kunal SoodGermantown$70K
- Ali TurabiBethesda$47K
- Behnam JafarpourBaltimore$45K
- Eric FinkelsteinOwings Mills$37K
- Ankush JainBethesda$26K
- Sudhir RaoMount Airy$25K
- Reza GhorbaniGreenbelt$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.